Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5924 Target Snapshot

Ubiquitin-like modifier-activating enzyme 1 · SINGLE PROTEIN · Homo sapiens

168Compounds
38Assays
0Approved Drugs
136.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P22314. Use UniProt P22314 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P22314 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Ubiquitin-like modifier-activating enzyme 1 as ChEMBL target CHEMBL5924, mapped to UniProt P22314. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Ubiquitin-like modifier-activating enzyme 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL5924
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P22314
Ubiquitin-like modifier-activating enzyme 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Ubiquitin-like modifier-activating enzyme 1 is the right protein anchor across sources, using UniProt P22314 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelUbiquitin-like modifier-activating enzyme 1
UniProt AccessionP22314
Component TypeProtein
Sequence Length1058 aa

Ubiquitin-like modifier-activating enzyme 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Ubiquitin-like modifier-activating enzyme 1, mapped to UniProt P22314. Sequence length is 1058 aa.

Mapped IDP22314
Review nameUbiquitin-like modifier-activating enzyme 1
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50133.0
KD3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5747752 7.26 IC50 55.0 Preclinical
CHEMBL5759269 7.26 IC50 55.0 Preclinical
CHEMBL5768102 7.26 IC50 55.0 Preclinical
CHEMBL5780833 7.26 IC50 55.0 Preclinical
CHEMBL5803994 7.26 IC50 55.0 Preclinical
CHEMBL5828810 7.26 IC50 55.0 Preclinical
CHEMBL5832385 7.26 IC50 55.0 Preclinical
CHEMBL5864078 7.26 IC50 55.0 Preclinical
CHEMBL5887314 7.26 IC50 55.0 Preclinical
CHEMBL5918592 7.26 IC50 55.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
1
5.5
12
6.0
0
6.5
20
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

38
Total Assays
36
Tested Compounds
1
Assay Types
Binding — 38 assays, 36 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 20 33 6.7
cell-based format 10 2 6.2
assay format 8 1 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine